Establishment and Characterization of Free-Floating 3D Macrophage Programming Model in the Presence of Cancer Cell Spheroids

Reprogramming of tumor-associated macrophages (TAMs) is a promising strategy for cancer immunotherapy. Several studies have shown that cancer cells induce/support the formation of immunosuppressive TAMs phenotypes. However, the specific factors that orchestrate this immunosuppressive process are unknown or poorly studied. In vivo studies are expensive, complex, and ethically constrained. Therefore, 3D cell interaction models could become a unique framework for the identification of important TAMs programming factors. In this study, we have established and characterized a new in vitro 3D model for macrophage programming in the presence of cancer cell spheroids. First, it was demonstrated that the profile of cytokines, chemokines, and surface markers of 3D-cultured macrophages did not differ conceptually from monolayer-cultured M1 and M2-programmed macrophages. Second, the possibility of reprogramming macrophages in 3D conditions was investigated. In total, the dynamic changes in 6 surface markers, 11 cytokines, and 22 chemokines were analyzed upon macrophage programming (M1 and M2) and reprogramming (M1→M2 and M2→M1). According to the findings, the reprogramming resulted in a mixed macrophage phenotype that expressed both immunosuppressive and anti-cancer immunostimulatory features. Third, cancer cell spheroids were shown to stimulate the production of immunosuppressive M2 markers as well as pro-tumor cytokines and chemokines. In summary, the newly developed 3D model of cancer cell spheroid/macrophage co-culture under free-floating conditions can be used for studies on macrophage plasticity and for the development of targeted cancer immunotherapy.

[1]  Wannian Yang,et al.  The Role of CXC Chemokines in Cancer Progression , 2022, Cancers.

[2]  A. Zajakina,et al.  Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations , 2022, Biomedicines.

[3]  Q. Liao,et al.  CD38: A Significant Regulator of Macrophage Function , 2022, Frontiers in Oncology.

[4]  T. Gajewski,et al.  Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma , 2021, Journal for ImmunoTherapy of Cancer.

[5]  Lei Wu,et al.  Inflammation and tumor progression: signaling pathways and targeted intervention , 2021, Signal Transduction and Targeted Therapy.

[6]  Liang Zhao,et al.  Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer , 2021, Cancer & Metabolism.

[7]  G. Palano,et al.  Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function , 2020, Cancer Research.

[8]  D. Aldinucci,et al.  The CCL5/CCR5 Axis in Cancer Progression , 2020, Cancers.

[9]  D. DeNardo,et al.  Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer , 2020, Frontiers in Oncology.

[10]  Rong Wang,et al.  CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL-2 and TGF-β by CD4+ T cells via the STAT5 signaling pathway , 2020, Molecular medicine reports.

[11]  Xikun Zhou,et al.  Tumor-Associated Macrophages: Recent Insights and Therapies , 2020, Frontiers in Oncology.

[12]  M. Raes,et al.  Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathway , 2020, Scientific Reports.

[13]  H. Yaegashi,et al.  Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis , 2019, Cancers.

[14]  J. Konen,et al.  The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors , 2019, Cells.

[15]  Noa Sher,et al.  IFN-β is a macrophage-derived effector cytokine facilitating the resolution of bacterial inflammation , 2019, Nature Communications.

[16]  Nese Unver.  Macrophage chemoattractants secreted by cancer cells: Sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target. , 2019, Cytokine & growth factor reviews.

[17]  D. Klinman,et al.  PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus. , 2019, Journal of autoimmunity.

[18]  C. Caux,et al.  Cold Tumors: A Therapeutic Challenge for Immunotherapy , 2019, Front. Immunol..

[19]  Jana Markhoff,et al.  Comparison of different cell culture plates for the enrichment of non-adherent human mononuclear cells , 2019, Experimental and therapeutic medicine.

[20]  E. Jaffee,et al.  Transcriptional profiling identifies novel regulators of macrophage polarization , 2018, PloS one.

[21]  E. Müller,et al.  Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation , 2018, Front. Immunol..

[22]  S. Satpathi,et al.  Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF‐κB activation and recurrent dexamethasone administration fails to suppress it in vivo , 2018, The Prostate.

[23]  S. Tai,et al.  Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization , 2018, Nature Communications.

[24]  Qi Wang,et al.  CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling , 2018, Cell Death & Disease.

[25]  Xiaomei Lu,et al.  IL‐1β from M2 macrophages promotes migration and invasion of ESCC cells enhancing epithelial‐mesenchymal transition and activating NF‐κB signaling pathway , 2018, Journal of cellular biochemistry.

[26]  M. Ferrer,et al.  A high-throughput imaging and nuclear segmentation analysis protocol for cleared 3D culture models , 2018, Scientific Reports.

[27]  L. Ni,et al.  Interferon gamma in cancer immunotherapy , 2018, Cancer medicine.

[28]  T. Papenfuss,et al.  CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions , 2018, Front. Immunol..

[29]  A. E. Rossi,et al.  A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity , 2018, Front. Immunol..

[30]  Z. Zhuang,et al.  Fatty acid oxidation contributes to IL‐1&bgr; secretion in M2 macrophages and promotes macrophage‐mediated tumor cell migration , 2018, Molecular immunology.

[31]  A. Zajakina,et al.  Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ , 2017, Front. Immunol..

[32]  K. Beraki,et al.  Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages , 2017, Front. Immunol..

[33]  M. Alexander,et al.  Image based Machine Learning for identification of macrophage subsets , 2017, Scientific Reports.

[34]  R. Koenen,et al.  Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation , 2017, Science Translational Medicine.

[35]  C. Heidecke,et al.  Differential S1P Receptor Profiles on M1- and M2-Polarized Macrophages Affect Macrophage Cytokine Production and Migration , 2017, BioMed research international.

[36]  M. Arnaout.  Biology and structure of leukocyte β 2 integrins and their role in inflammation , 2016, F1000Research.

[37]  Yizheng Wang,et al.  Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis , 2016, Oncogene.

[38]  M. Emberton,et al.  The next level of 3D tumour models: immunocompetence. , 2016, Drug discovery today.

[39]  M. Rantalainen,et al.  Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis. , 2016, Cell reports.

[40]  D. Kaplan,et al.  Bioelectric modulation of macrophage polarization , 2016, Scientific Reports.

[41]  J. Weiss,et al.  Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells , 2016, Front. Immunol..

[42]  Phillip G. Popovich,et al.  Novel Markers to Delineate Murine M1 and M2 Macrophages , 2015, PloS one.

[43]  P. Sly,et al.  Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. , 2015, American journal of respiratory cell and molecular biology.

[44]  M. Raes,et al.  M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide , 2015, BMC Cancer.

[45]  S. Singhal,et al.  CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer. , 2015, Cancer research.

[46]  D. Hoskin,et al.  4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory Responses , 2015, PloS one.

[47]  M. Detmar,et al.  Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer , 2015, Scientific Reports.

[48]  S. Xiong,et al.  The chemotaxis of M1 and M2 macrophages is regulated by different chemokines , 2015, Journal of leukocyte biology.

[49]  F. Behbod,et al.  Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins , 2014, BMC Cancer.

[50]  Nadia J. T. Roumans,et al.  Wound Administration of M2-Polarized Macrophages Does Not Improve Murine Cutaneous Healing Responses , 2014, PloS one.

[51]  D. Dréau,et al.  Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling , 2014, Angiogenesis.

[52]  Zachary D. Kurtz,et al.  Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. , 2014, Blood.

[53]  P. Lizotte,et al.  Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis , 2014, Oncoimmunology.

[54]  Qiang Xu,et al.  Pentamethoxyflavanone regulates macrophage polarization and ameliorates sepsis in mice. , 2014, Biochemical pharmacology.

[55]  G. Vunjak‐Novakovic,et al.  The role of macrophage phenotype in vascularization of tissue engineering scaffolds. , 2014, Biomaterials.

[56]  H. D. de Vries,et al.  Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation , 2014, Journal of Neuroinflammation.

[57]  D. Hume,et al.  IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1 , 2013, The Journal of experimental medicine.

[58]  E. Tsai,et al.  Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway , 2013, Oncogene.

[59]  E. Fisher,et al.  HDL Induces the Expression of the M2 Macrophage Markers Arginase 1 and Fizz-1 in a STAT6-Dependent Process , 2013, PloS one.

[60]  R. Pestell,et al.  The CCL5/CCR5 axis promotes metastasis in basal breast cancer , 2013, Oncoimmunology.

[61]  C. Payne,et al.  Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy , 2012, Proceedings of the National Academy of Sciences.

[62]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[63]  Hong Wang,et al.  Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice , 2011, PloS one.

[64]  P. Carmeliet,et al.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. , 2011, Cancer cell.

[65]  P. De Baetselier,et al.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.

[66]  P. Allavena,et al.  The chemokine system in cancer biology and therapy. , 2010, Cytokine & growth factor reviews.

[67]  S. Briest,et al.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. , 2009, Cancer research.

[68]  J. Blay,et al.  Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. , 2009, Cancer research.

[69]  Kei Kuratomi,et al.  Growth Inhibitory Effects of IFN-β on Human Liver Cancer Cells In Vitro and In Vivo , 2007 .

[70]  J. Suttles,et al.  IL-12 Rapidly Alters the Functional Profile of Tumor-Associated and Tumor-Infiltrating Macrophages In Vitro and In Vivo1 , 2007, The Journal of Immunology.

[71]  S. Gordon,et al.  Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype1 , 2006, The Journal of Immunology.

[72]  J. Suttles,et al.  Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences1 , 2005, The Journal of Immunology.

[73]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[74]  J. Suttles,et al.  Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.

[75]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[76]  S. Horita,et al.  High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma. , 2004, The Journal of urology.

[77]  B. Bloom,et al.  Regulation of macrophage growth and antiviral activity by interferon- gamma , 1989, The Journal of cell biology.

[78]  Gordana Vunjak-Novakovic,et al.  Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. , 2015, Biomaterials.

[79]  O. Fardel,et al.  Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. , 2013, Cellular immunology.

[80]  Charles D Mills,et al.  M1 and M2 Macrophages: Oracles of Health and Disease. , 2012, Critical reviews in immunology.

[81]  M. Zygmunt,et al.  Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells , 2012, Breast Cancer Research and Treatment.